Cyrille Tupin
Chief Executive Officer bei ABIONYX PHARMA
Vermögen: 2 Mio $ am 31.03.2024
Profil
Cyrille Tupin is currently the Chief Executive Officer & Director at ABIONYX Pharma SA since 2019.
He is also the Chief Executive Officer at Cerenis Therapeutics, Inc. and BUTS SAS.
Previously, he worked as an Audit Director at Sygnatures SA and as a Principal at PricewaterhouseCoopers LLP.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ABIONYX PHARMA SA
4,72% | 18.11.2022 | 1 533 001 ( 4,72% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Cyrille Tupin
Unternehmen | Position | Beginn |
---|---|---|
ABIONYX PHARMA | Chief Executive Officer | 06.09.2019 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Cyrille Tupin
Unternehmen | Position | Ende |
---|---|---|
Sygnatures SA
Sygnatures SA Miscellaneous Commercial ServicesCommercial Services Sygnatures SA is an independent group that specializes in accounting, auditing, and consulting services. The private company is based in Toulouse, France and has subsidiaries in France. Sygnatures has been operating in the Occitanie region for over 30 years. The CEOs of the French company are Philippe Benzoni and Dominique Louit. | Comptroller/Controller/Auditor | - |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ABIONYX PHARMA | Health Technology |
Private Unternehmen | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Sygnatures SA
Sygnatures SA Miscellaneous Commercial ServicesCommercial Services Sygnatures SA is an independent group that specializes in accounting, auditing, and consulting services. The private company is based in Toulouse, France and has subsidiaries in France. Sygnatures has been operating in the Occitanie region for over 30 years. The CEOs of the French company are Philippe Benzoni and Dominique Louit. | Commercial Services |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Health Technology |